Favipiravir and hydroxychloroquine combination therapy in patients with moderate to severe COVID-19 (FACCT Trial): an open-label, multicenter, randomized …
Introduction Antiviral drugs have shown limited effectiveness in treating patients with
coronavirus disease 2019 (COVID-19). We aimed to assess the effects of a favipiravir and …
coronavirus disease 2019 (COVID-19). We aimed to assess the effects of a favipiravir and …